David R. Spigel

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

David R. Spigel
Sep 16, 2024, 14:34 | Insight
New standard of care for Limited-Stage Small-Cell Lung Cancer, summary by Estela Rodriguez 
Estela Rodriguez shared a post on X: "Out today in ADRIATIC New England Journal of Medicine…
Jul 5, 2024, 02:47 | Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jun 29, 2024, 10:28 | Blog
David R. Spigel's presentation at the 2024 ASCO on crucial developments in lung cancer treatment - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: “David R. Spigel, presentation at the…
Jun 27, 2024, 05:29 | Blog
Chandler Park: An honor to co-host with Cathy Eng for the ASCO24 Nashville review
Chandler Park shared on LinkedIn:     . “That was FUN! It was an honor to…
Jun 23, 2024, 09:25 | Insight
David R. Spigel comments on CROWN, LAURA, and ADRIATIC studies
Sarah Cannon Docs shared on X: ""It's just kind of blown everyone away that the…
Jun 19, 2024, 07:37 | Blog
Narjust Florez: Check out my interview with David R. Spigel for The ASCO Post
Narjust Florez shared a post by The ASCO Post on X, adding the following: . “Check…
Jun 18, 2024, 09:57 | Insight
Top 5 articles of the week - Cancer Network
Cancer Network shared on X/Twitter: "View our top 5 articles of the week: T-DXd Boosts…
Jun 15, 2024, 15:32 | Blog
Yüksel Ürün: As a GU oncologist my non-GU key highlights from ASCO24
Yüksel Ürün shared on X/Twitter: "As a GU oncologist my non-GU key highlights from ASCO24. 1.…
Jun 13, 2024, 07:33 | Blog
Narjust Florez: Stay tuned for a discussion on lung cancer data presented at ASCO24
Narjust Florez shared a post on X: "Stay tuned for an incredible discussion about the lung…
Jun 8, 2024, 16:06 | Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 8, 2024, 03:53 | Societies
25 Posts From ASCO24 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 4, 2024, 03:22 | Blog
Vivek Subbiah: Our amazing CSO Dr. Spigel will be presenting at the big plenary!
Vivek Subbiah shared on X/Twitter: "ASCO24 Sunday morning! Starting the day with Skip Burris, Conquer Cancer,…
Jun 3, 2024, 15:25 | Societies
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 25, 2024, 09:42 | Societies
SCRI Oncology Partners introduces its members
Sarah Cannon Research Centre (SCRI) Oncology Partners shared on LinkedIn: With our new LinkedIn page, we…
May 23, 2024, 13:26 | Blog
Aakash Desai: Here are the top 5 abstracts you don't want to miss from ASCO24
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared a post on LinkedIn: "Exciting…
May 21, 2024, 05:27 | Insight
David R. Spigel reflects on the vital role of clinical research in cancer care - Sarah Cannon Docs
Sarah Cannon Docs shared on X: "Hear from our Chief Scientific Officer, Dr. David R.…
Apr 26, 2024, 20:26 | Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Mar 12, 2024, 10:02 | Blog
Vivek Subbiah: Grateful to have Jason Dorsey deliver a phenomenal and energetic keynote at the 27th Annual Scientific Meeting of SCRI! 
Vivek Subbiah shared a post on LinkedIn: "Grateful to have Jason Dorsey an acclaimed speaker, deliver…
All: 18 Posts: 1 - 100
Special Coverage